PARK AVENUE SECURITIES LLC
Broker-DealerPosition in NBIX — Neurocrine Biosciences Inc
CIK 1071640
NEW YORK, NY
Position in NBIX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,449,612
+$429,023 QoQ
Shares Held
8,601
+11.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#350
of 768 holders
Holding Since
Jun 2020
23 quarters on record
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $5,937,881 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
8,601 | $1,449,612 | |
| 2 | HLN |
Haleon plc
|
111,923 | $1,044,241 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
14,734 | $942,239 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
44,827 | $718,576 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
19,191 | $650,191 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,038 | $562,419 | |
| 7 | ZTS |
Zoetis Inc.
|
4,994 | $358,868 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
12,232 | $211,735 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,449,612 | 8,601 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,020,589 | 7,747 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,175,770 | 8,290 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $1,138,481 | 8,110 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,017,334 | 8,094 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $783,379 | 7,083 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $966,420 | 7,080 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $661,823 | 5,744 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $1,367,476 | 9,933 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,319,894 | 9,570 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,247,635 | 9,469 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,005,862 | 8,941 | Shares | Sole | 2023-10-26 | |
| 2022-12-31 | $1,021,570 | 8,553 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $905,121 | 8,522 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $898,570 | 9,218 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $742,312 | 7,918 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $328,245 | 3,854 | Shares | Sole | 2022-04-08 | |
| 2021-09-30 | $554,072 | 5,777 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $507,426 | 5,214 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $396,585 | 4,078 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $325,219 | 3,393 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $295,788 | 3,076 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $233,142 | 1,911 | Shares | Sole | 2020-07-30 | |
| No filing history on record for this holder in this stock. | ||||||